Evidence map›Paper›PMID 31635493›Full record

ArticleChronic respiratory disease

High-flow nasal cannula therapy reduced the respiratory rate and respiratory distress in a standard model simulator and in patients with hypoxemic respiratory failure.

Akira Motoyasu, Kiyoshi Moriyama, Hiromu Okano, Tomoko Yorozu

Abstract read
In one paragraph

Article in Chronic respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akira MotoyasuDepartment of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.
Kiyoshi MoriyamaDepartment of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.ORCID 0000-0002-0387-5406
Hiromu OkanoDepartment of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.
Tomoko YorozuDepartment of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-flow nasal cannula (HFNC) therapy has been increasingly applied to treat patients with severe hypoxemic respiratory failure. We investigated whether vital signs reflect the reduction of work of breathing in a simulator study and a clinical study. In the simulator study, a standard model high-fidelity human patient simulator (HPS) directly received 35 L/minute of 100% O

Indexed as

Work of BreathingAgedAged, 80 and overCannulaComputer SimulationFemaleHeart RateHumansHypoxiaMaleOxygenOxygen Inhalation TherapyPartial PressurePulmonary AlveoliRespiratory InsufficiencyRespiratory RateOxygenHigh-flow nasal cannula therapyhuman patient simulatorrespiratory distressrespiratory ratevital signs

Identifiers

PMID31635493
PMCPMC6804361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.